Growth Metrics

Cardio Diagnostics Holdings (CDIO) Depreciation & Amortization (IS) (2022 - 2025)

Historic Depreciation & Amortization (IS) for Cardio Diagnostics Holdings (CDIO) over the last 4 years, with Q1 2025 value amounting to $45438.0.

  • Cardio Diagnostics Holdings' Depreciation & Amortization (IS) rose 84800.75% to $45438.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $60383.0, marking a year-over-year increase of 21465.87%. This contributed to the annual value of $19738.0 for FY2024, which is 289.86% up from last year.
  • Cardio Diagnostics Holdings' Depreciation & Amortization (IS) amounted to $45438.0 in Q1 2025, which was up 84800.75% from $5349.0 recorded in Q4 2024.
  • Cardio Diagnostics Holdings' Depreciation & Amortization (IS)'s 5-year high stood at $45438.0 during Q1 2025, with a 5-year trough of $4000.0 in Q1 2022.
  • Moreover, its 4-year median value for Depreciation & Amortization (IS) was $4793.0 (2023), whereas its average is $7719.8.
  • Its Depreciation & Amortization (IS) has fluctuated over the past 5 years, first changed by 0.0% in 2024, then skyrocketed by 84800.75% in 2025.
  • Cardio Diagnostics Holdings' Depreciation & Amortization (IS) (Quarter) stood at $4000.0 in 2022, then grew by 20.05% to $4802.0 in 2023, then increased by 11.39% to $5349.0 in 2024, then skyrocketed by 749.47% to $45438.0 in 2025.
  • Its Depreciation & Amortization (IS) was $45438.0 in Q1 2025, compared to $5349.0 in Q4 2024 and $4802.0 in Q3 2024.